Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.27M Sell
119,518
-3,738
-3% -$198K 0.07% 196
2026
Q1
$6.8M Sell
123,256
-4,486
-4% -$243K 0.08% 182
2025
Q4
$6.26M Buy
127,742
+200
+0.2% +$9.33K 0.08% 188
2025
Q3
$5.5M Sell
127,542
-6,317
-5% -$247K 0.07% 201
2025
Q2
$5.14M Buy
+133,859
New +$5.11M 0.07% 205

Other funds holding GSK

Midwest Trust's GSK Position: Q2 2026 in Review

Midwest Trust reduced its GSK (GSK) stake by 3% in Q2 2026, selling an estimated $198K and leaving 119,518 shares worth $6.27M. The position accounts for 0.07% of the portfolio, ranked #196.

Midwest Trust first reported a position in GSK in Q2 2025 and has held it in 5 quarters since. The position peaked at $6.8M in Q1 2026. 1,040 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Midwest Trust held 119,518 shares of GSK worth $6.27M as of Q2 2026.
  • Midwest Trust sold 3,738 GSK shares in Q2 2026, an estimated $198K.
  • GSK made up 0.07% of Midwest Trust's portfolio in Q2 2026, its #196 holding.
  • Midwest Trust first reported a position in GSK in Q2 2025 and has held it in 5 quarters since.
  • Midwest Trust's GSK position peaked at $6.8M in Q1 2026.
  • 1,040 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Midwest Trust's 13F filing for Q2 2026, filed 5 Aug 2026.